Jennifer Doudna

Close up of pink azalea flowers
Biotech

In vivo gene editing biotech blossoms from Jennifer Doudna's lab

Azalea Therapeutics will use the funds to push an in vivo CAR-T therapy for B-cell malignancies into the clinic within the next 12 to 18 months.
Darren Incorvaia Nov 4, 2025 8:00am
KJ Muldoon graduates from the hospital and heads home for the first time

Center launches with $20M to create CRISPR therapies for kids

Jul 8, 2025 11:59am
gene edits scientists gene editing CRISPR

CRISPR pioneer Doudna allies with Danaher on gene editing center

Jan 9, 2024 9:17am
DNA gene therapy gene editing helix CRISPR

Chromosome loss from CRISPR-Cas9 stopped by swapping steps

Oct 9, 2023 7:40am
scribe papyrus papers feather pen jot write archive

Scribe's CRISPR tech Prevails with new $1.5B Lilly biobucks deal

May 16, 2023 9:00am
An IGI researcher plates bacterial cultures in the Innovative Genomics Institutes BIOME lab where researchers study how to

Jennifer Doudna's next great CRISPR challenge: cow burps

Apr 20, 2023 3:45pm